We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Protein Identified That Maintains Embryonic Stem Cell Pluripotency

By LabMedica International staff writers
Posted on 05 Oct 2014
Print article
Image: Following inhibition of a key protein, these embryonic stem cells underwent differentiation and lost their pluripotency. (Nuclei are in green and nuclei expressing pluripotency factors are in blue and red) (Photo courtesy of Dr. Raffaella Di Micco, New York University Langone Medical Center).
Image: Following inhibition of a key protein, these embryonic stem cells underwent differentiation and lost their pluripotency. (Nuclei are in green and nuclei expressing pluripotency factors are in blue and red) (Photo courtesy of Dr. Raffaella Di Micco, New York University Langone Medical Center).
A protein that is critical in maintaining stem cells in their primitive pluripotentive state was identified and discussed in a recently published paper.

Investigators at the New York University Langone Medical Center (NY, USA) had previously found that the protein BRD4 (bromodomain-containing protein 4) promoted the growth and spread of melanoma by keeping the cancer cells in a relatively immature, stem cell-like state.

In the current study, published in the September 25, 2014, online edition of the journal Cell Reports, the investigators demonstrated in mouse and human embryonic stem cells (ESCs) that BRD4 regulated the capacity for self-renewal and pluripotency. When BRD4 was inhibited chemically or through the use of siRNA, this resulted in induction of epithelial-to-mesenchymal transition (EMT) markers and commitment to the maturation into neural cells while reducing the ESC multi-differentiation capacity in teratoma assays.

BRD4 maintained the transcription of core stem cell genes such as OCT4 and PRDM14 by occupying their super-enhancers (SEs), large clusters of regulatory elements, and recruiting to them Mediator and CDK9, the catalytic subunit of the positive transcription elongation factor b (P-TEFb), to allow Pol-II-dependent productive elongation.

"OCT4 is one of the four factors in the standard "OKSM" cocktail used for turning ordinary cells into induced pluripotent stem cells (iPSCs)," said senior author Dr. Eve Hernando-Monge, associate professor of pathology at the New York University Langone Medical Center. "The new findings suggest that BRD4 enforces stem cell identity from an even higher regulatory level in the cell. In theory we could replace one or more of those OKSM factors with BRD4, or add it to the cocktail to increase reprogramming efficiency—that is something we are working on now."

Related Links:

New York University Langone Medical Center


Gold Member
Hematology Analyzer
Swelab Lumi
Automated Blood Typing System
IH-500 NEXT
New
Vitamin B12 Test
CHORUS CLIA VIT B12
New
Silver Member
Apolipoprotein A-I Assay
Apo A-I Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.